RE-LY/RELY-ABLE

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Trial Purpose

The purposes of this study are:

  • To evaluate the long-term safety of dabigatran etexilate
  • To assess the effect of a knowledge translation intervention on patient outcomes

Patient Eligibility Requirements

This study is ongoing, but not recruiting participants.


Links

clinicaltrials.gov →
New England Journal of Medicine Article on Averroes →

Capital Cardiology Associates - A Benchmark Cardiology Practice